The complexity of malaria has precluded many "slam dunk" attempts at a vaccine. In this issue, Minassian et al.1 present efficacy trial results that demonstrate progress for a much-anticipated malaria vaccine candidate and pave the way to future iterations by validating a comprehensive vaccine development framework.
Copyright © 2021 Elsevier Inc. All rights reserved.